Concord Medical Services Holdings (CCM)

NYSE

Currency in USD

4.680

-0.410(-8.06%)

Closed15:59:59

After Hours

4.750+0.070(+1.496%)

16:10:00

Fair Value

Day's Range

4.660

5.300

52 wk Range

3.818

26.700

CCM Income Statement

Explore the detailed Concord Medical Services Holdings income statement, offering a comprehensive view of the company’s financial performance. Review essential metrics such as revenue, gross profit, operating income, and net income over selected periods. This page provides a clear breakdown of profitability and operational efficiency, helping you evaluate Concord Medical Services Holdings's growth trends and overall financial health.

Advanced Income Statement

Period Ending:

2014

31/12

2015

31/12

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

Total Revenues

198.36

223.01

485.63

472.09

537.4

Total Revenues Growth

+3.91%

+12.43%

+117.76%

-2.79%

+13.84%

Cost Of Revenues

214.19

209.93

542.53

624.49

614.01

Gross Profit

-15.83

13.08

-56.9

-152.41

-76.61

Gross Profit Growth

-180.1%

+182.65%

-534.89%

-167.87%

+49.74%

Gross Profit Margin %

-7.98%

5.87%

-11.72%

-32.28%

-14.26%

Other Operating Expenses, Total

345.38

320.58

401.42

372.64

386.38

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+10.14%	-7.18%	+25.22%	-7.17%	+3.69%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	345.38	320.58	401.42	372.64	386.38
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

-361.21

-307.5

-458.32

-525.05

-462.99

Operating Income Growth

-22.94%

+14.87%

-49.05%

-14.56%

+11.82%

EBIT Margin %

-182.09%

-137.89%

-94.38%

-111.22%

-86.15%

Net Interest Expenses

-19.54

-72.92

-67.9

-110.34

-154.84

Net Interest Expenses Growth

+39.07%

-273.27%

+6.89%

-62.51%

-40.33%

Interest Expense, Total

-28.7

-81.36

-73.79

-120.36

-165.67

Interest And Investment Income

9.17

8.44

5.89

10.02

10.83

Other Non Operating Expenses, Total

35.15

-46.35

-3.02

61.29

25.31

EBT, Excl. Unusual Items

-345.59

-426.77

-529.24

-574.1

-592.52

Gain (Loss) On Sale Of Assets

-1.3

-14.22

-

-61.55

-0.58

Other Unusual Items, Total

-76.09

-8.5

-

-204.25

-

EBT, Incl. Unusual Items

-391.08

-441.65

-529.24

-839.9

-555.59

EBT, Incl. Unusual Items Growth

-73.62%

-12.93%

-19.83%

-58.7%

+33.85%

EBT, Incl. Unusual Items Margin

-197.15%

-198.04%

-108.98%

-177.91%

-103.39%

Income Tax Expense

-38.99

-37.62

-6.57

-70.91

-24.57

Net Income to Company

-352.09

-404.03

-522.67

-768.99

-531.02

Minority Interest

45.04

94.04

251.25

279.33

233.36

Net Income

-307.05

-309.99

-271.43

-489.66

-297.66

Net Income Growth

-30.73%

-0.96%

+12.44%

-80.4%

+39.21%

Net Income Margin %

-154.79%

-139%

-55.89%

-103.72%

-55.39%

Preferred Dividend and Other Adjustments

245.48

359.92

549.19

-

-

Net Income to Common Excl. Extra Items

-552.53

-669.91

-820.62

-489.66

-297.66

Basic EPS - Continuing Operations

-127.27

-153.35

-187.85

-112.09

-68.14

Basic EPS - Continuing Operations Growth

-53.65%

-20.49%

-22.5%

+40.33%

+39.21%

Diluted EPS - Continuing Operations

-127.27

-153.35

-187.85

-112.09

-68.14

Diluted EPS - Continuing Operations Growth

-53.65%

-20.49%

-22.5%

+40.33%

+39.21%

Basic Weighted Average Shares Outstanding

4.34

4.37

4.37

4.37

4.37

Diluted Weighted Average Shares Outstanding

4.34

4.37

4.37

4.37

4.37

Dividend Per Share

-

-

-

-

-

Dividend Per Share Growth

-

-

-

-

-

EBITDA

-304.85

-236.72

-363.86

-401.86

-344.16

EBITDA Growth

-22.53%

+22.35%

-53.71%

-10.44%

+14.36%

EBITDA Margin %